Skip to content

The 95% effective concentration of ropivacaine were detected under adductor canal block combined with interspace between the popliteal artery and the capsule of the posterior knee for postoperative analgesia after total knee arthroplasty and pain condition/stress/postoperative recovery were observed.

The 95% effective concentration of ropivacaine were detected under adductor canal block combined with interspace between the popliteal artery and the capsule of the posterior knee for postoperative analgesia after total knee arthroplasty and pain condition/stress/postoperative recovery were observed.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071148
Enrollment
Unknown
Registered
2023-05-06
Start date
2023-05-16
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Observation on analgesia of total knee arthroplasty

Interventions

Ropivacaine group:Various concentrations of ropivacaine with 40mL volume
low doses Dexmedetomidine + Ropivacaine group:Various concentrations of ropivacaine and Dexmedetomidine with 40mL volume
high doses Dexmedetomidine + Ropivacaine group:Various concentrations of ropivacaine and Dexmedetomidine with 40mL volume

Sponsors

Affiliated Hospital of Nantong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 75 Years

Inclusion criteria

Inclusion criteria: Gender is not limited, ASA grade I-III, aged 55-75 years, body mass index (BMI) 20-29kg / ?. Patients with normal intelligence, ability to understand and willing to participate in this study, and willing to sign informed consent.

Exclusion criteria

Exclusion criteria: Patients with severe cardiopulmonary function, liver and kidney dysfunction; Patients with allergic history of related drugs;the patient was not able or willing to cooperate with testing and assessments; Patients with a long history of gastric ulcer and gas-trorrhagia; Patients cannot tolerate a nerve block; Patients with a contraindication for puncture;Patients with a long history of painful diseases; Patients with a history of drug or alcohol dependence; Contraindications for general anaesthesia; Patients with severe cardiopulmonary function, liver and kidney dysfunction; Patients with high blood pressure, diabetes, mental disorders and mental disorders.

Design outcomes

Primary

MeasureTime frame
VAS Scoring;EC50 by sequential approach;

Secondary

MeasureTime frame
Demographic data;nerve block-related conditions;Resuscitation situations;Prognosis of the studied patients;Adverse effects;

Countries

China

Contacts

Public ContactZhongLing Xu

Affiliated Hospital of Nantong University

fJhxzL@163.com+86 13815218918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026